Clinical Trials Logo

Clinical Trial Summary

Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns. Intrauterine devices (IUDs) are the leading reversible contraceptive method used in the world, but only 20.7% of women in France were using them in 2010. In practice, in France, use of the IUD is still "reserved" for older women or those who have already had children, despite medical recommendations. In this study the investigator will investigate whether clear information about the mode of action and insertion/withdrawal of IUDs would dispel these misconceptions of patients.


Clinical Trial Description

Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns. Intrauterine devices (IUDs) are the leading reversible contraceptive method used in the world, but only 20.7% of women in France were using them in 2010. In practice in France, the use of IUDs is still "reserved" for older women or those who have already had children, despite medical recommendations. Indeed, there is a certain feeling of mistrust towards the IUD as a contraceptive method. Sometimes the patient's reasons for refusal were unclear or misconceptions and prejudices prevailed. Various research studies and theses have identified the various obstacles to the use of the IUD as a contraceptive. Today it would be interesting to evaluate whether a short presentation of the IUD during a consultation would lead to a better acceptance of women to use it as a possible contraceptive method. In this study the investigators will investigate whether clear information about the mode of action and insertion/removal of IUDs would dispel these misconceptions of patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05317715
Study type Interventional
Source Raincy Montfermeil Hospital Group
Contact Jean GUILLEMINOT, MD
Phone 01 41 70 81 19
Email jean.guilleminot@ght-gpne.fr
Status Recruiting
Phase N/A
Start date April 14, 2022
Completion date October 2022

See also
  Status Clinical Trial Phase
Completed NCT03750864 - Innovative Approach to Reduce Lung Cancer Stigma N/A
Completed NCT03917329 - Evaluation of an ACT and PBS Group for Parents and Education Staff N/A
Completed NCT05071768 - Virtual Focused ACT Groups in Primary Care N/A
Completed NCT02196454 - Video to Promote HPV Vaccination N/A
Active, not recruiting NCT03693911 - ACT to Prevent Eating Disorders: Evaluating a Gamified Prevention Program N/A
Terminated NCT05244265 - Mindfulness Based Stress Reduction for Intellectually Able Autistic Adults N/A
Completed NCT06139471 - Efficacy of a Virtual Reality-Enhanced Gagne's Instructional Model N/A
Completed NCT03339986 - Downsizing: Snacking in Preschool Children N/A
Completed NCT05576701 - Laughter Therapy Application in Hemodialysis Patients N/A
Completed NCT02354183 - Commitment and Motivation in a Brief DBT Intervention for Self Harm N/A